BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 19019178)

  • 1. J1-31 protein expression in astrocytes and astrocytomas.
    Shuangshoti S; Thorner PS; Ruangvejvorachai P; Saha B; Groshen S; Taylor CR; Malhotra S; Imam SA
    Neuropathology; 2009 Oct; 29(5):521-7. PubMed ID: 19019178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of gemistocytes in astrocytoma progression.
    Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H
    Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas.
    Lang FF; Miller DC; Pisharody S; Koslow M; Newcomb EW
    Oncogene; 1994 Mar; 9(3):949-54. PubMed ID: 8108140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of glial fibrillary acidic protein (GFAP) with grading of the neuroglial tumours.
    Reyaz N; Tayyab M; Khan SA; Siddique T
    J Coll Physicians Surg Pak; 2005 Aug; 15(8):472-5. PubMed ID: 16202357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
    Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
    Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression pattern of alpha-protein kinase C in human astrocytomas indicates a role in malignant progression.
    Benzil DL; Finkelstein SD; Epstein MH; Finch PW
    Cancer Res; 1992 May; 52(10):2951-6. PubMed ID: 1316231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein D expression in primary brain tumors: analysis by quantitative RT-PCR in formalin-fixed, paraffin-embedded tissue.
    Hunter SB; Varma V; Shehata B; Nolen JD; Cohen C; Olson JJ; Ou CY
    J Histochem Cytochem; 2005 Aug; 53(8):963-9. PubMed ID: 16055749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 protein alterations in adult astrocytic tumors and oligodendrogliomas.
    Nayak A; Ralte AM; Sharma MC; Singh VP; Mahapatra AK; Mehta VS; Sarkar C
    Neurol India; 2004 Jun; 52(2):228-32. PubMed ID: 15269478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44 expression in astrocytic tumors.
    Ylagan LR; Quinn B
    Mod Pathol; 1997 Dec; 10(12):1239-46. PubMed ID: 9436970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant p53 expression in astrocytic neoplasms of the brain: association with proliferation.
    Haapasalo H; Isola J; Sallinen P; Kalimo H; Helin H; Rantala I
    Am J Pathol; 1993 May; 142(5):1347-51. PubMed ID: 7684193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An isomorphic subtype of long-term epilepsy-associated astrocytomas associated with benign prognosis.
    Blümcke I; Luyken C; Urbach H; Schramm J; Wiestler OD
    Acta Neuropathol; 2004 May; 107(5):381-8. PubMed ID: 15034726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical detection of p53 protein expression in various childhood astrocytoma subtypes: significance in tumor progression.
    Bodey B; Gröger AM; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1997; 17(2A):1187-94. PubMed ID: 9137469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Numb expression in astrocytomas.
    Yan B; Omar FM; Das K; Ng WH; Lim C; Shiuan K; Yap CT; Salto-Tellez M
    Neuropathology; 2008 Oct; 28(5):479-84. PubMed ID: 18384513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annexin II marks astrocytic brain tumors of high histologic grade.
    Roseman BJ; Bollen A; Hsu J; Lamborn K; Israel MA
    Oncol Res; 1994; 6(12):561-7. PubMed ID: 7787249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
    Hlobilkova A; Ehrmann J; Sedlakova E; Krejci V; Knizetova P; Fiuraskova M; Kala M; Kalita O; Kolar Z
    Neoplasma; 2007; 54(4):334-41. PubMed ID: 17822324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are endothelial cell patterns of astrocytomas indicative of grade?
    Selby DM; Woodard CA; Henry ML; Bernstein JJ
    In Vivo; 1997; 11(5):371-5. PubMed ID: 9427037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diversity of glial cell components in pilocytic astrocytoma.
    Tanaka Y; Sasaki A; Ishiuchi S; Nakazato Y
    Neuropathology; 2008 Aug; 28(4):399-407. PubMed ID: 18312545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical localization of basic fibroblast growth factor in astrocytomas.
    Zagzag D; Miller DC; Sato Y; Rifkin DB; Burstein DE
    Cancer Res; 1990 Nov; 50(22):7393-8. PubMed ID: 2171762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of p53-protein expression and the PCNA and Ki-67 proliferating cell indices in human astrocytomas.
    Kordek R; Biernat W; Debiec-Rychter M; Alwasiak J; Liberski PP
    Pathol Res Pract; 1996 Mar; 192(3):205-9. PubMed ID: 8739466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.